OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Target Corp/  US87612E1064  /

IEX
6/13/2024  9:59:57 PM Chg. -2.17 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
144.62USD -1.48% 101,011
Turnover: 14.65 mill.		 -Bid Size: - -Ask Size: - 66.93 bill.USD 3.03% 16.15
GlobeNewswire 12:00 PM Five Historic Properties, Formerly Held by Caltrans, Coming Back on the Market in South Pasadena wit...
GlobeNewswire 12:00 PM Greenwich LifeSciences Announces $2.5 Million Private Placement
GlobeNewswire 12:00 PM The Ensign Group, Inc. Declares Quarterly Dividend of $0.06 Per Share
GlobeNewswire 12:00 PM Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Tria...
GlobeNewswire 12:00 PM Norsk Hydro: Save the date - Capital Markets Day to be held in London on November 27, 2024
GlobeNewswire 11:00 AM Study: Texas Housing Markets Moderating Among Sunbelt States
TeleTrader 10:55 AM French far-right Le Pen promises 'unity gov't' if party wins
TeleTrader 10:24 AM Wall Street mostly lower premarket after economic data
TeleTrader 9:51 AM Russia slams US-Ukraine 10-year security deal
GlobeNewswire 9:15 AM HSBC Bank plc: Post Stabilisation Notice
GlobeNewswire 9:11 AM Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire 9:05 AM Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings Report
GlobeNewswire 9:02 AM Flash News: OKX Announces Exclusive Minting of Slerf NFTs on its Marketplace
TeleTrader 9:02 AM European markets mixed at open amid data releases
GlobeNewswire 9:01 AM Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire 9:00 AM Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire 9:00 AM Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire 9:00 AM Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire 8:00 AM Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
TeleTrader 7:47 AM Duma speaker: US sanctions erode confidence in dollar
GlobeNewswire 7:30 AM Azerion initiates a Written Procedure and launches a Subsequent Bond Issue
GlobeNewswire 7:22 AM Flash News: OKX Wallet Now Integrated with DragonSwap
TeleTrader 7:15 AM Japan's Nikkei 225 turns to gains after BoJ rate call
GlobeNewswire 7:00 AM Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
GlobeNewswire 7:00 AM WISeKey Announces Retirement of Peter Ward as Chief Financial Officer; Appoints John O’Hara as its N...